Slovenian state co-funding agreement for orphan drug signed
Science Minister Igor Papič and Špela Miroševič, the head of a foundation developing a treatment for the the CTNNB1 syndrome, signed an agreement under which the state will co-fund pre-clinical and clinical studies for the gene therapy Urbagen, named after Miroševič's son Urban, who has the syndrome, CE Report quotes STA.
More details at the link.
